Lépine Sarah, Nauleau-Javaudin Angela, Deneault Eric, Chen Carol X-Q, Abdian Narges, Franco-Flores Anna Krystina, Haghi Ghazal, Castellanos-Montiel María José, Maussion Gilles, Chaineau Mathilde, Durcan Thomas Martin
Early Drug Discovery Unit (EDDU), The Neuro-Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3A 1A1, Canada.
Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
iScience. 2024 Feb 9;27(3):109166. doi: 10.1016/j.isci.2024.109166. eCollection 2024 Mar 15.
Cytoplasmic mislocalization and aggregation of the RNA-binding protein TDP-43 is a pathological hallmark of the motor neuron (MN) disease amyotrophic lateral sclerosis (ALS). Furthermore, while mutations in (encoding TDP-43) have been associated with ALS, the pathogenic consequences of these mutations remain poorly understood. Using CRISPR-Cas9, we engineered two homozygous knock-in induced pluripotent stem cell lines carrying mutations in encoding TDP-43 and TDP-43, two common yet understudied ALS TDP-43 variants. Motor neurons (MNs) differentiated from knock-in iPSCs had normal viability and displayed no significant changes in TDP-43 subcellular localization, phosphorylation, solubility, or aggregation compared with isogenic control MNs. However, our results highlight synaptic impairments in both TDP-43 and TDP-43 MN cultures, as reflected in synapse abnormalities and alterations in spontaneous neuronal activity. Collectively, our findings suggest that MN dysfunction may precede the occurrence of TDP-43 pathology and neurodegeneration in ALS and further implicate synaptic and excitability defects in the pathobiology of this disease.
Neuropathol Appl Neurobiol. 2016-6-28
Front Neurosci. 2023-10-2
Regen Ther. 2025-8-13
Cell Death Discov. 2025-2-23
Protein J. 2025-4
Mol Neurobiol. 2025-1
Curr Issues Mol Biol. 2024-4-30
Int J Mol Sci. 2023-2-27
Stem Cell Reports. 2023-3-14
Transl Neurodegener. 2022-12-27